Colin Walsh, Director at Attovia Therapeutics, Inc. (ATTO), sold 105,607 shares at $22.03 ($2.2M) on 2026-08-05, disclosed to the SEC on 2026-08-13.
Open-market sale of $2.2M ATTO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.84 | 300 | $6K | 0.3% |
| 2 | $21.04 | 76,418 | $1.6M | 71.5% |
| 3 | $21.55 | 480 | $10K | 0.5% |
| 4 | $21.61 | 6,763 | $146K | 6.5% |
| 5 | $21.78 | 443 | $10K | 0.4% |
| 6 | $21.84 | 1,180 |
| $26K |
| 1.1% |
| 7 | $21.87 | 447 | $10K | 0.4% |
| 8 | $21.97 | 753 | $17K | 0.7% |
| 9 | $21.99 | 100 | $2K | 0.1% |
| 10 | $22.02 | 400 | $9K | 0.4% |
| 11 | $22.02 | 672 | $15K | 0.7% |
| 12 | $22.02 | 3,402 | $75K | 3.3% |
| 13 | $22.03 | 1,332 | $29K | 1.3% |
| 14 | $22.03 | 6,970 | $154K | 6.8% |
| 15 | $22.03 | 988 | $22K | 1.0% |
| 16 | $22.05 | 200 | $4K | 0.2% |
| 17 | $22.05 | 1,040 | $23K | 1.0% |
| 18 | $22.06 | 1,556 | $34K | 1.5% |
| 19 | $22.07 | 700 | $15K | 0.7% |
| 20 | $22.10 | 200 | $4K | 0.2% |
| 21 | $22.11 | 100 | $2K | 0.1% |
| 22 | $22.19 | 1,163 | $26K | 1.1% |
| Total | $21.28 avg | 105,607 | $2.2M | 100% |